| Huateng Pharma Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.huatengsci.com | |||
![]() | +86 (731) 8205-5395 | |||
![]() | +86 (731) 8960-9225 | |||
![]() | 613609811@qq.com | |||
![]() | QQ Chat | |||
| Chemical distributor since 2013 | ||||
| chemBlink Standard supplier since 2014 | ||||
| Pure Chemistry Scientific Inc | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.purechems.com | |||
![]() | +1 (888) 588-9418 | |||
![]() | +1 (617) 206-9595 | |||
![]() | sales@purechems.com | |||
| Chemical manufacturer since 2004 | ||||
| chemBlink Standard supplier since 2014 | ||||
| Hangzhou Leap Chem Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.leapchem.com | |||
![]() | +86 (571) 8771-1850 | |||
![]() | market19@leapchem.com | |||
![]() | QQ Chat | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink Standard supplier since 2015 | ||||
| Eburon Organics bvba | Belgium | Inquire | ||
|---|---|---|---|---|
![]() | www.eburon-organics.com | |||
![]() | +32 (51) 335-068 | |||
![]() | +32 (51) 335-064 | |||
![]() | sales@eburon-organics.com | |||
| Chemical manufacturer | ||||
| Classification | Organic raw materials >> Organometallic compound >> Organotin |
|---|---|
| Name | trans-1,2-Bis(tributylstannyl)ethene |
| Synonyms | (E)-1,2-Bis(tributylstannyl)ethene; (E)-1,2-Bis(tributylstannyl)ethylene; (E)-1,2-Bis(tributyltin)ethylene; (E)-1,2-Ethenediylbis[tributylstannane] |
| Molecular Structure | ![]() |
| Molecular Formula | C26H56Sn2 |
| Molecular Weight | 606.14 |
| CAS Registry Number | 14275-61-7 |
| EC Number | 664-439-5 |
| Solubility | Insoluble (4.2E-6 g/L) (25 °C), Calc.* |
|---|---|
| Density | 1.15 g/cm3** |
| Melting point | 180-182 °C*** |
| Refractive index | 1.503** |
| * | Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2013 ACD/Labs) |
| ** | "Metal-Organics Catalog" physical property data were obtained from Gelest, Inc. of Morrisville, Pennsylvania (US) |
| *** | Nesmeyanov, A. N. |
| Hazard Symbols | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Statements | R21;R25;R36/38;R48/23/25;R50/53 Details | ||||||||||||||||||||||||||||||||||||||||||||||||
| Safety Statements | S36/37/39;S45;S60;S61 Details | ||||||||||||||||||||||||||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for trans-1,2-Bis(tributylstannyl)ethene |